Generation Bio (GBIO) Stock: Buy, Sell, or Hold?
$5.34
-0.40 (-6.97%)
âŧ
5d:
-4.47%
30d:
-2.38%
90d:
+2.89%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (59%)
Quality Score
43/100
Position
FAIR
Forward P/E & Valuation
-0.7x
Next 12M consensus est.
Wall Street Target
$5.25
-1.7% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$5.44 / $5.77
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GBIO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GBIO is currently trading at $5.34, which is considered fair based on recent price action.
Technical Outlook: Technically, GBIO is in a downtrend. The price is currently testing key support at $5.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GBIO is in a downtrend. The price is currently testing key support at $5.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
58.9%
Trading Range & Key Levels
Support Level
$5.44
Resistance Level
$5.77
Current Trend
Downtrend
Technical data as of
Feb 6, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-7.0%)
- NEUTRAL: Near Wall St target ($5.25)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.69
Wall Street Target
$5.25
(-1.7%)
Revenue Growth (YoY)
-78.9%
Share GBIO Analysis
Share this live GBIO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GBIO)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2025
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment dominates on StockTwits regarding Generation Bio (GBIO) due to ongoing strategic review and potential mergers or financing updates in the biopharma and hospitality industries.
Key Retail Themes:
Strategic review and potential mergers or financing updates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:13 PM ET
Data refreshes hourly during market hours. Next update: 8:13 PM
Data refreshes hourly during market hours. Next update: 8:13 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
SNDX
Syndax Pharmaceuticals IâĻ |
STRONG BUY
12 analysts |
$35 | 60 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GBIO Research Pages
